Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Comparison Tests01:13

Multiple Comparison Tests

4.0K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
4.0K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

243
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
243

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

[Secondary diabetes].

Ugeskrift for laeger·2026
Same authorSame journal

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same authorSame journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Gaining biological insights through supervised data visualization.

Nature computational science·2026
Same author

Cerebellar magnetization transfer ratio and its relationship to clinical outcomes in radiologically isolated syndrome and multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Interaction between smoking and <i>HLA-A*02:01</i> in multiple sclerosis progression.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Related Experiment Video

Updated: Aug 9, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K

Comparative effectiveness in multiple sclerosis: A methodological comparison.

Izanne Roos1, Ibrahima Diouf2, Sifat Sharmin2

  • 1CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia/Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|February 21, 2023
PubMed
Summary
This summary is machine-generated.

Propensity score matching and marginal structural models effectively compare fingolimod and natalizumab for multiple sclerosis (MS). Both methods showed natalizumab reduced relapse risk and improved disability, with no significant difference between techniques.

Keywords:
Observationalcausal inferencemultiple sclerosis

More Related Videos

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.5K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.7K

Related Experiment Videos

Last Updated: Aug 9, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.5K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.7K

Area of Science:

  • Epidemiology
  • Biostatistics
  • Clinical Pharmacology

Background:

  • Observational data can emulate randomized controlled trials (RCTs) to inform clinical decisions when RCTs are absent.
  • Observational studies face challenges like confounding and bias, necessitating advanced statistical techniques.
  • Propensity score matching and marginal structural models are key methods to mitigate indication bias in observational research.

Purpose of the Study:

  • To compare the effectiveness of fingolimod versus natalizumab in multiple sclerosis (MS) treatment.
  • To evaluate and compare the performance of propensity score matching and marginal structural models in this comparison.

Main Methods:

  • Utilized the MSBase registry to identify patients with clinically isolated syndrome or relapsing-remitting MS treated with fingolimod or natalizumab.
  • Applied propensity score matching and inverse probability of treatment weighting (marginal structural models) at six-month intervals.
  • Analyzed outcomes including cumulative relapse hazard, disability accumulation, and disability improvement, adjusting for covariates like age, sex, and disease characteristics.

Main Results:

  • Compared 1659 natalizumab patients with 2949 fingolimod patients after matching/weighting.
  • Natalizumab demonstrated a reduced probability of relapse (HR 0.67-0.71) and increased probability of disability improvement (1.21-1.43) compared to fingolimod.
  • Both propensity score matching and marginal structural models yielded consistent results, indicating no significant difference in their effect magnitude.

Conclusions:

  • Propensity score matching and marginal structural models are efficient tools for comparing the relative effectiveness of therapies in well-defined clinical settings.
  • These methods are reliable when applied to sufficiently powered observational cohorts.
  • The study validates the use of these statistical approaches for comparative effectiveness research in MS.